Binaytara shared a post on LinkedIn:
“Kaposi sarcoma tells a powerful story about global cancer inequity.
In high-income countries, it’s now rare and manageable.
In sub-Saharan Africa, it remains a leading cause of cancer death.
In this expert commentary, Dr. David Aboulafia (Virginia Mason Franciscan Health) breaks down:
- Why KS remains so prevalent globally
- The critical role of HIV treatment (ART)
- The real barriers preventing equitable cancer care
- What needs to change to close the gap
Read here.”
Other articles from Binaytara.